HYPERCHOLESTEROLAEMIA
Clinical trials for HYPERCHOLESTEROLAEMIA explained in plain language.
Never miss a new study
Get alerted when new HYPERCHOLESTEROLAEMIA trials appear
Sign up with your email to follow new studies for HYPERCHOLESTEROLAEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Gut bacteria supplement aims to tackle high cholesterol
Disease control Recruiting nowThis study tests whether a daily probiotic called AKM Lab-01 can safely lower cholesterol levels in adults aged 40 to 60 with high cholesterol. Participants will take either the probiotic or a placebo for a period, and researchers will compare changes in blood cholesterol and oth…
Matched conditions: HYPERCHOLESTEROLAEMIA
Phase: NA • Sponsor: Moon (Guangzhou) Biotechnology Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:10 UTC
-
New shot aims to slash cholesterol after heart attacks
Disease control Recruiting nowThis study tests whether adding a new drug called inclisiran to standard care can lower 'bad' cholesterol more than standard care alone in people who have recently had a heart attack, stroke, or urgent heart procedure. About 520 adults will be randomly assigned to receive either …
Matched conditions: HYPERCHOLESTEROLAEMIA
Phase: PHASE4 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
CRISPR therapy targets stubborn high cholesterol in first human trial
Disease control Recruiting nowThis study is testing a new treatment called CTX310, which uses CRISPR gene editing to turn off a gene linked to high cholesterol and fats. It is for adults aged 18 to 75 whose lipid levels remain high despite standard treatments. The goal is to see if the therapy is safe and can…
Matched conditions: HYPERCHOLESTEROLAEMIA
Phase: PHASE1 • Sponsor: CRISPR Therapeutics AG • Aim: Disease control
Last updated May 19, 2026 11:48 UTC
-
Italian registry to reveal Real-World use of cholesterol drug
Knowledge-focused Recruiting nowThis study is a registry that will observe 1,500 Italian adults already taking alirocumab 300 mg for high cholesterol. Researchers want to see how consistently patients take the medication, how long they stay on it, and how much their LDL (bad) cholesterol drops. It also tracks s…
Matched conditions: HYPERCHOLESTEROLAEMIA
Sponsor: Federico II University • Aim: Knowledge-focused
Last updated May 26, 2026 03:06 UTC